Biotricity (BTCY) Institutional Ownership $0.33 -0.06 (-15.50%) (As of 09/16/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Biotricity (NASDAQ:BTCY)CurrentInstitutional OwnershipPercentage3.89%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$204.97KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$962.42K Get BTCY Insider Trade Alerts Want to know when executives and insiders are buying or selling Biotricity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BTCY Institutional Buying and Selling by Quarter Ad Brownstone Research My big AI project…On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.Just click here to register. Biotricity Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2024 AE Wealth Management LLC97,751$88K0.0%N/A0.452% 4/19/2024Advisor Resource Council79,070$117K0.0%N/A0.839% 10/30/2023 Strengthening Families & Communities LLC48,263$103K0.0%-83.3%0.563% 10/11/2023 AE Wealth Management LLC41,684$89K0.0%-83.3%0.486% (Data available from 1/1/2016 forward) BTCY Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BTCY shares? During the previous two years, the following institutional investors and hedge funds held shares of Biotricity shares: Advisor Resource Council ($117K), and Strengthening Families & Communities LLC ($103K), AE Wealth Management LLC ($88K).Learn more on BTCY's institutional investors. What percentage of Biotricity stock is owned by institutional investors? 3.89% of Biotricity stock is owned by institutional investors. Learn more on BTCY's institutional investor holdings. Which institutional investors have been buying Biotricity stock? The following institutional investors have purchased Biotricity stock in the last 24 months: AE Wealth Management LLC ($97.75K), and Advisor Resource Council ($79.07K). How much institutional buying is happening at Biotricity? Institutional investors have bought a total of 176,821 shares in the last 24 months. This purchase volume represents approximately $204.97K in transactions. Which Biotricity major shareholders have been selling company stock? The following institutional investors have sold Biotricity stock in the last 24 months: Strengthening Families & Communities LLC ($241.31K), and AE Wealth Management LLC ($208.42K). How much institutional selling is happening at Biotricity? Institutional investors have sold a total of 449,728 shares in the last 24 months. This volume of shares sold represents approximately $962.42K in transactions. Related Companies: Allurion Technologies Major Shareholders SurgePays Major Shareholders Meihua International Medical Technologies Major Shareholders ReWalk Robotics Major Shareholders Outset Medical Major Shareholders Femasys Major Shareholders DarioHealth Major Shareholders Spectral AI Major Shareholders Neuronetics Major Shareholders Pixie Dust Technologies Major Shareholders This page (NASDAQ:BTCY) was last updated on 9/17/2024 by MarketBeat.com Staff From Our PartnersBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredAI Detects Profit Surge On MondayThis has given investors the opportunity to beat the market by 1,700% and a 100% win rate to begin the year.Monument Traders Alliance | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredForget polls, focus on these 5 tickersWith all the geopolitical tensions in the world… all the inflation… all the expectations of a new round of Fed...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.